Bicycle Therapeutics plc: CFO Travis Alvin Thompson sold 972 shares

What happened

• Travis Alvin Thompson, chief financial officer, sold a total of 972 shares in two open-market transactions: 893 shares on Oct 2, 2026 at a weighted average price of $3.47 for $3,099, and 79 shares on Oct 5, 2026 at a weighted average price of $3.57 for $282.

Key details

• Transaction dates and prices: Oct 2, 2026 — 893 shares at weighted avg $3.47 (prices ranged $3.41 to $3.525); Oct 5, 2026 — 79 shares at weighted avg $3.57 (prices ranged $3.56 to $3.57).
• Shares owned after the transaction: not reported in this filing.
• Footnotes: the Oct 2 sale was a mandated "sell to cover" to satisfy statutory tax withholding per the award agreement; the filing notes weighted-average pricing and offers to provide per-trade breakdowns on request.
• Filing timeliness: filing date Oct 6, 2026; no late filing flag indicated.

Why it may matter

• The Oct 2 sale was a sell-to-cover transaction to fund tax withholding tied to the vesting and settlement of RSUs, which the filing says was mandated by the award agreement and not a discretionary sale. The Oct 5 sale was an open-market sale reported separately.
• A filing does not show why the insider traded or why the company acted.